دورية أكاديمية

1520O REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

التفاصيل البيبلوغرافية
العنوان: 1520O REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
المؤلفون: Martin Broto, J., Valverde, C., Hindi, N., Vincenzi, B., Martinez-Trufero, J., Grignani, G., Italiano, A., Lavernia, J., Gonzalez-Campora, R., Vallejo, A., Hernandez-Jover, D., Gutierrez, A., Serrano, C., Moura, D., Lopez-Guerrero, J.A., Cruz, J., Fernández-Serra, A., Blay, J-Y., Fumagalli, E.R., Martinez Marin, V.
المصدر: In Annals of Oncology September 2021 32 Supplement 5:S1111-S1111
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.08.850